Evidence map›Paper›PMID 36981857›Full record

ArticleInternational journal of environmental research and public health2023

Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools.

Joanna M Gaitens, Melissa Culligan, Joseph S Friedberg, Erica Glass, Maxwell Reback, Katherine A Scilla, Ashutosh Sachdeva, Anthony Atalla, Melissa A McDiarmid

Open access · goldFull text read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joanna M GaitensSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0003-1285-679X
Melissa CulliganSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0003-4305-8715
Joseph S FriedbergSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0002-4945-5589
Erica GlassSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Maxwell RebackSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Katherine A ScillaSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0001-7904-8119
Ashutosh SachdevaSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0001-6491-8740
Anthony AtallaSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0009-0003-9907-6231
Melissa A McDiarmidSchool of Medicine, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0003-3455-9147
University of Maryland, Baltimore · US

Funding

CDC HHS 75D30119P05558NIOSH CDC HHS U24 OH009077
6 · The paper itself

Abstract

Mesothelioma, a cancer of mesothelial cells that line the chest, lungs, heart, and abdomen, is a relatively rare disease. In the United States, approximately 3000 individuals are diagnosed with mesothelioma annually. The primary risk factor for mesothelioma is occupational asbestos exposure which can occur decades prior to disease development, though in approximately 20% of cases, known asbestos exposure is lacking. While several other countries have developed mesothelioma registries to collect key clinical and exposure data elements to allow better estimation of incidence, prevalence, and risk factors associated with disease development, no national mesothelioma registry exists in the U.S. Therefore, as part of a larger feasibility study, a patient exposure questionnaire and a clinical data collection tool were created using a series of key informant interviews. Findings suggest that risk factor and clinical data collection via an on-line questionnaire is feasible, but specific concerns related to confidentiality, in the context of employer responsibility for exposure in the unique U.S. legal environment, and timing of enrollment must be addressed. Lessons learned from piloting these tools will inform the design and implementation of a mesothelioma registry of national scope.

Indexed as

AsbestosMesotheliomaMesothelioma, MalignantOccupational ExposureHumansIncidenceRegistriesSurveys and QuestionnairesUnited StatesAsbestosasbestos exposuremesotheliomaregistry

Identifiers

PMID36981857
PMCPMC10049120
OpenAlexW4324095529

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read5
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.